MOFFITT CANCER CENTER M
LIVE

Serial Number

76687026

Owner

H. Lee Moffitt Cancer Center and Research Institute, Inc.

Attorney

Corey K. Cho

First Use Date

Nov 30, 2007

Filing Date

Feb 22, 2008

Add to watchlist:

No watchlists yet
View on USPTO

MOFFITT CANCER CENTER M Trademark

Serial Number: 76687026 • Registration: 3671302

MOFFITT CANCER CENTER M is a trademark filed by H. Lee Moffitt Cancer Center and Research Institute, Inc. on February 22, 2008. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

H. Lee Moffitt Cancer Center and Research Institute, Inc. (151 trademarks)

MRC-TTO
Tampa, FL 336129497

Entity Type: 99

Trademark Details

Filing Date

February 22, 2008

Registration Date

August 25, 2009

First Use Anywhere

November 30, 2007

First Use in Commerce

November 30, 2007

Published for Opposition

June 9, 2009

Goods & Services

Medical educational services, namely, conducting lectures, seminars and workshops to health care practitioners, patients and patient caregivers in the field of health care, cancer care and prevention of cancer, and medical diagnostics, prognostics and the evaluation of drug and treatment effectiveness relating to cancer and other diseases

Publications, namely, printed instructional and teaching materials, brochures, pamphlets, bulletins, newsletters and magazines, all in the field of health care, cancer protection, prevention, detection and treatment, medical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases

Providing health care, medical information and counseling in the field of cancer; providing medical screening and diagnostic services with use of patient scanning equipment; providing an online computer database featuring medical information in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; medical services, namely, cancer care and prevention of cancer, and medical diagnostics, prognostics and evaluation of drug and treatment effectiveness relating to cancer and other diseases; medical counseling; telephone hot line counseling, namely, offering advice regarding cancer prevention, detection, treatment and clinical testing in the field of cancer and other diseases

Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicians, patients and researchers, namely, an online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing data regarding tumor-specific molecular signatures and the effectiveness of a drug and/or diagnostic test for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes for research purposes; medical research services consisting of collection and analysis of data in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, matching particular patients to a particular drug, treatment, therapy or clinical trial by the specific molecular signature of the patient; collection and analysis of data services in the field of human clinical and molecular data accumulation and analysis for research assistance for medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, providing objective data in usable form on the effectiveness of a drug or diagnostic test

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 23, 2019 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Mar 23, 2019 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 23, 2019 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 20, 2019 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 7, 2019 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 25, 2018 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 23, 2014 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 22, 2014 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 22, 2014 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 3, 2014 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2014 TCCA
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2009 R.PR
PUBLISHED FOR OPPOSITION
Jun 9, 2009 PUBO
NOTICE OF PUBLICATION
May 20, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 5, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2009 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 28, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 13, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 1, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 18, 2009 GNRN
NON-FINAL ACTION E-MAILED
Feb 18, 2009 GNRT
NON-FINAL ACTION WRITTEN
Feb 18, 2009 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2009 CRFA
ASSIGNED TO LIE
Jan 22, 2009 ALIE
ASSIGNED TO LIE
Jan 22, 2009 ALIE
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 17, 2008 CHAN
ASSIGNED TO LIE
Dec 17, 2008 ALIE
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 8, 2008 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 8, 2008 REAP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2008 TROA
NON-FINAL ACTION MAILED
Jun 16, 2008 CNRT
NON-FINAL ACTION WRITTEN
Jun 14, 2008 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2008 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 4, 2008 MAFR
NEW APPLICATION ENTERED
Feb 28, 2008 NWAP